TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM $3.71B
1-Year Return
19.93%
This Quarter Return
-4.45%
1 Year Return
+19.93%
3 Year Return
+90.1%
5 Year Return
+158.53%
10 Year Return
+284.02%
AUM
$10.5B
AUM Growth
+$4.68B
(+81%)
Cap. Flow
+$5.03B
Cap. Flow
% of AUM
48.1%
Top 10 Holdings %
Top 10 Hldgs %
29.39%
Holding
7,240
New
777
Increased
2,878
Reduced
2,426
Closed
830
Top Buys
| 1 |
Apple
AAPL
|
+$429M |
| 2 |
Microsoft
MSFT
|
+$350M |
| 3 |
Amazon
AMZN
|
+$222M |
| 4 |
Tesla
TSLA
|
+$150M |
| 5 |
NVIDIA
NVDA
|
+$137M |
Top Sells
| 1 |
Technology Select Sector SPDR Fund
XLK
|
+$51.9M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$45.3M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$35.2M |
| 4 |
Consumer Discretionary Select Sector SPDR Fund
XLY
|
+$27.5M |
| 5 |
iShares Russell 1000 ETF
IWB
|
+$11.9M |
Sector Composition
| 1 | Technology | 30.52% |
| 2 | Consumer Discretionary | 11.81% |
| 3 | Healthcare | 9.84% |
| 4 | Communication Services | 9.46% |
| 5 | Financials | 9.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3976
Forte Biosciences
FBRX
$160M
| $13K | ﹤0.01% |
354
+170
| +92% | +$6.24K |
|
3977
Five Star Bancorp
FSBC
$718M
| $13K | ﹤0.01% |
470
+98
| +26% | +$2.71K |
|
3978
Great Lakes Dredge & Dock
GLDD
$851M
| $13K | ﹤0.01% |
960
-49
| -5% | -$664 |
|
|
HOOK
3979
DELISTED
HOOKIPA Pharma
HOOK
| $13K | ﹤0.01% |
536
-1,397
| -72% | -$33.9K |
|
3980
HarborOne Bancorp
HONE
$581M
| $13K | ﹤0.01% |
947
-343
| -27% | -$4.71K |
|
3981
Ichor Holdings
ICHR
$608M
| $13K | ﹤0.01% |
350
+150
| +75% | +$5.57K |
|
3982
Insteel Industries
IIIN
$760M
| $13K | ﹤0.01% |
336
-240
| -42% | -$9.29K |
|
3983
International Seaways
INSW
$2.41B
| $13K | ﹤0.01% |
681
-341
| -33% | -$6.51K |
|
3984
Lifetime Brands
LCUT
$88.6M
| $13K | ﹤0.01% |
1,028
-726
| -41% | -$9.18K |
|
3985
Neurogene
NGNE
$270M
| $13K | ﹤0.01% |
348
-9
| -3% | -$336 |
|
3986
Nicolet Bankshares
NIC
$2.03B
| $13K | ﹤0.01% |
142
-68
| -32% | -$6.23K |
|
|
NNDM
3987
Nano Dimension
NNDM
$304M
| $13K | ﹤0.01% |
3,789
-1,459
| -28% | -$5.01K |
|
3988
Neuropace
NPCE
$334M
| $13K | ﹤0.01% |
1,632
+506
| +45% | +$4.03K |
|
3989
NRX Pharmaceuticals
NRXP
$71.8M
| $13K | ﹤0.01% |
513
+491
| +2,232% | +$12.4K |
|
3990
Nuvectis Pharma
NVCT
$165M
| $13K | ﹤0.01% |
+1,750
| New | +$13K |
|
3991
ON24
ONTF
$247M
| $13K | ﹤0.01% |
945
+365
| +63% | +$5.02K |
|
3992
Ovid Therapeutics
OVID
$81.1M
| $13K | ﹤0.01% |
3,993
+212
| +6% | +$690 |
|
3993
Palomar
PLMR
$3.11B
| $13K | ﹤0.01% |
204
-1,507
| -88% | -$96K |
|
3994
Pulse Biosciences
PLSE
$1.22B
| $13K | ﹤0.01% |
2,630
+1,551
| +144% | +$7.67K |
|
3995
PROS Holdings
PRO
$772M
| $13K | ﹤0.01% |
400
-2,843
| -88% | -$92.4K |
|
3996
Quanterix
QTRX
$257M
| $13K | ﹤0.01% |
452
-678
| -60% | -$19.5K |
|
3997
Ryvyl
RVYL
$8.81M
| $13K | ﹤0.01% |
316
-752
| -70% | -$30.9K |
|
3998
RxSight
RXST
$381M
| $13K | ﹤0.01% |
1,028
-982
| -49% | -$12.4K |
|
3999
Sera Prognostics
SERA
$121M
| $13K | ﹤0.01% |
3,519
+2,161
| +159% | +$7.98K |
|
4000
Society Pass
SOPA
$7.45M
| $13K | ﹤0.01% |
285
+81
| +40% | +$3.7K |
|